Pharmacopsychiatry

Papers
(The median citation count of Pharmacopsychiatry is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
An Oppositional Tolerance Account for Potential Cognitive Deficits Caused by the Discontinuation of Antidepressant Drugs153
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation58
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study45
23
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?23
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study18
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry18
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries17
Neuronal Correlates of Delusional Symptomatology in Affective and Psychotic Disorders16
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study15
CircRNAs in Peripheral Blood: Potential Biomarkers for Alzheimer’s Disease?15
The Mini-TRH Test15
Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports15
13
Predicting mental health symptoms with NBS-Predict13
13
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS12
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA12
Epigenetics for Drug Discovery: Dissecting the Effect of High Antipsychotic Dosage and D2 Blockage on Peripheral DNA Methylation11
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response9
News on the Role of Antidepressants in and for COVID-19 and Long COVID9
8
Amphiphysin und GAD65 IgG Antikörper bei Zwangsstörungen8
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey8
Comparison of Sodium Lactate Infusion and Carbon Dioxide Inhalation Panic Provocation Tests: A Meta-analysis7
7
6
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes6
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie6
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab5
5
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis5
Impaired nonverbal communication is associated with symptom severity in Depression5
Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexita5
Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?4
Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use4
Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials4
Overview: Chronic Pain and Cannabis-Based Medicines4
Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review4
5-HTTLPR-rs25531 and Antidepressant Treatment Outcomes in Korean Patients with Major Depression4
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics4
4
Longitudinal Multimodal Analysis of Structural Brain Changes and Psychopathology Using Data-Driven Fusion Approaches4
Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa3
Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges3
Investigating the role of CCL11 in shaping microglial age-and long-COVID-related inflammatory activation3
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs3
Monitoring Anesthetic Depth Using the Patient State Index in Electroconvulsive Therapy Improves Seizure Quality3
Predicting one-year postoperative cognitive dysfunction after cardiac surgery by combining markers of amyloid-β and tau pathology3
Das therapeutische Potential von niedrig dosiertem Δ9-Tetrahydrocannabinol bei der Modulation der Alzheimer-Pathologie im 5xFAD-Mausmodell3
Reward System in Schizophrenia: Characterizing Clinical and Neurobiological Underpinnings with Regard to Sexuality3
Metformin is Protective Against the Development of Mood Disorders3
2
Digital Phenotyping and Mobile Sensing in Addiction Psychiatry2
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study2
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatme2
Brain Fog reconsidered. Objectifying subjective cognitive impairment following COVID-19 infection.2
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie2
2
Impact of Parkinson Medication on Neuropsychiatric and Neurocognitive Symptoms in Patients with Advanced Parkinson Disease Prior to Deep Brain Stimulation1
In major depression early response to antidepressant treatment in week one is associated with FKBP5-gene variants rs1360780 and rs47139161
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum D1
Effectiveness of Medical Cannabis for the Treatment of Depression: A Naturalistic Outpatient Study1
Implications of Online Self-Diagnosis in Psychiatry1
1
Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring1
Einfluss einer traumafokussierten Psychotherapie auf Zwangs- und somatoformen Symptome: Design einer klinischen Längsschnittstudie1
Human Derived Dermal Fibroblasts as in Vitro Research Tool to Study Circadian Rhythmicity in Psychiatric Disorders1
Therapeutic Potential of the Novel GLP-1 Receptor Agonist Semaglutide in Alcohol Use Disorder1
Activation of Hippocampal Neuronal NADPH Oxidase NOX2 Promotes Depressive-Like Behaviour and Cognition Deficits in Chronic Restraint Stress Mouse Model1
Medical Cannabis Legalization: No Contribution to Rising Stimulant Rates in the USA1
Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis1
Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders1
Early Treatment-Resistance in First Episode Psychosis1
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine 1
Development of a Genetic Test Indicating Increased AVP/V1b Signalling in Patients with Acute Depression1
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study0
0
Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study0
0
Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature0
Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases0
Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-Analysis0
0
Neuroimaging-gestützte Charakterisierung von Schlafstörungen und Depressionen0
0
Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia0
The BIPCOVID Study: Investigating Shared Genetic Pathways Between COVID-19 Susceptibility and Psychiatric Symptoms in Bipolar Disorder0
Valproic Acid Induced Thrombocytopenia in an Elderly Man with Schizoaffective Disorder: A Case Report0
The Effect of Electroconvulsive Therapy on Specific Catatonia Symptoms and Predictors of Late Response0
COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine0
Early phase of a seronegative autoimmune psychosis with increased kappa free light chains0
Establishing Core Symptoms of Acute Serotonin Reuptake Inhibitor Withdrawal: Results from an International Survey of Online Peer-Support Communities0
Strategies and Management for Psychiatric Drug Withdrawal: A Systematic Review of Case Reports and Series0
Life-time Actionable Pharmacogenetic Drug Use: A Population-based Cohort Study in 86 040 Young People With and Without Mental Disorders in Denmark0
Citalopram als potenzielle Therapie und Prophylaxe für Alzheimer: Experimentelle Untersuchungen im 5xFAD-Mausmodell0
Psychedelics: A New Treatment Paradigm in Psychiatry?0
Anti-SARS-CoV-2 Action of Fluvoxamine may be Mediated by Endothelial Nitric Oxide Synthase0
Expression Biomarkers of Pharmacological Treatment Outcomes in Women with Unipolar and Bipolar Depression0
0
Failing Memory in Nonaffective Psychosis and Prolactin Response to 12.5 µg i.v. TRH0
DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy0
Entgiftung bei Alkoholabhängigen mit Clomethiazol oder Diazepam – Vergleich von Behandlungsvariablen0
Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedica0
Lithium Therapy in Old Age: Recommendations from a Delphi Survey0
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels0
Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial0
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson’s Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysis0
How to Improve Methodological Issues in Clinical Trials to Confirm that Pentoxifylline is Useful as an Add-on Therapy for Major Depressive Disorder0
A genome-wide association study of brain function across multiple cognitive domains0
Discontinuation Rate of Lurasidone and Quetiapine Extended Release in Bipolar Depression0
Candidate Psychotropics against SARS – CoV – 2: A Narrative Review0
Comparable Psychotropic Prescription Rates After Hospital Discharge Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory Infection0
Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties0
Transdiagnostic types of formal thought disorder and their association with gray matter brain structure: a model-based cluster analytic approach0
Stratifizierung des Risikos für die Anwendung von Zwangsmaßnahmen mit Hilfe von künstlicher Intelligenz und elektronischen Gesundheitsdaten0
Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder0
Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment0
The Therapeutic Potential of Pimavanserin in the Treatment of Hallucinogen Induced Psychosis and Persistent Perceptual Symptoms0
Rationale, Mission and Vision for a National Centre of Affective Disorders in Germany0
0
Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study0
Drug Combinations for Mood Disorders and Physical Comorbidities That Need Attention: A Cross-Sectional National Database Survey0
Predicting Future Cognitive Decline Using Novel fMRI-Based Biomarkers in Preclinical Alzheimer's Disease0
Geschlechter im Fokus: Welche Rolle spielt der 5-HT2C-Rezeptor in der lateralen Habenula in einem Mausmodell der schweren Depression?0
Correction: Lithium Therapy in Old Age: Recommendations from a Delphi Survey0
Cognitive Side Effects of Electroconvulsive Therapy: A Case-Control Comparison in Obsessive-Compulsive and Depressive Disorders0
Augmentation of Electroconvulsive Therapy with Oral Caffeine: A Retrospective Analysis of 40 Patients with Major Depression0
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Stu0
0
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice0
Reward System in Schizophrenia: Characterizing Clinical and Neurobiological Underpinnings with Regard to Sexuality0
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry0
„Peter Müller Preis für Forschung im Bereich Schizophrenie“ in Höhe von 5.000€0
Cannabinoids for Behavioral Symptoms in Dementia: An Overview0
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integratio0
Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammati0
Der Zusammenhang zwischen belastenden Lebensereignissen, DMN-Konnektivität und MDD- Remission: Eine fMRT-gestützte Analyse0
High Prescribing and State-Level Variation in Z-Drug Use Among Medicare Patients0
Medical Cannabis in Psychiatry0
Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease0
Neural links of paranoia in a transdiagnostic sample0
Was heißt hier Remission? Eine Sekundäranalyse der longitudinalen EMC-Studie0
Initial Evidence of CES1 Gene Variants Influencing the Pharmacokinetics and Clinical Effects of Methylphenidate0
Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment0
Morphological Representation of C1q in the Aging Central Nervous System0
0
Diversion and Abuse of Prescribed Methylphenidate – A Survey of an Outpatient Clinic for Adult Persons with ADHD0
Management of Refractory Functional Gastrointestinal Disorders: What Role Should Psychiatrists Have?0
Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System – V1b-antagonists as a Case in Point0
0
ABC Family Gene Polymorphisms and Cognitive Functions Interact to Influence Antidepressant Efficacy0
Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis0
Challenges and Ethical Considerations to Successfully Implement Artificial Intelligence in Clinical Medicine and Neuroscience: a Narrative Review0
Arzneimittelsicherheit in der Psychiatrie Hautexanthem mit Eosinophilie unter Lithium0
0
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature0
Hirnvolumetrie bei Patienten mit Alkoholabhängigkeit0
Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years0
Covid-19: Contributions from Psychopharmacology0
Clozapine-Induced Stuttering: Case Report and Literature Review0
Classic Psychedelic Drugs: Update on Biological Mechanisms0
Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German M0
Withanone Ameliorates Stress Symptoms in Caenorhabditis Elegans by Acting through Serotonin Receptors0
The Potential Role of Psychedelic Drugs in Mental Health Care of the Future0
Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism0
Untersuchung des Sozialverhaltens in einem Rattenmodell der bipolaren Störung0
Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression0
CYP1A2 Genotyp-abhängige Auswirkung des Rauchens auf die Mirtazapin Serumkonzentration0
0
„AGNP-Preis für Forschung in der Psychopharmakologie“ in Höhe von 5.000 €0
Pharmacological Treatment of Autism Spectrum Disorder: A Systematic Review of Treatment Guidelines0
Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany0
Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multic0
Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments0
0
A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection0
Effekte eines sechswöchigen hochfrequenten standardisierten Sportprogramms (SIWAS) auf die Herzfrequenzvariabilität bei Patient*innen mit psychiatrischen Erkrankungen0
Therapeutic Drug Monitoring of Cariprazine – Updated Values for a Dose-Related Reference Range0
Patient Perspectives on Pharmacotherapy of Alcohol Dependence0
Effects of long-term thiethylperazine treatment on Alzheimer's pathology in Tg4-42 mice: Therapeutic Potential vs. Adverse Effects0
Interpersonal Needs, Mental Pain, and Hopelessness in Psychiatric Inpatients with Suicidal Ideation0
Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine0
A Trajectory of Long-Term Antipsychotic Medication Dosage in Inpatients with Severe Behavioral and Psychological Symptoms of Dementia: A Retrospective Study0
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review0
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?0
0
COVID-19 Prognosis in Association with Antidepressant Use0
Association of Four Medication Classes and Non-suicidal Self-injury in Adolescents with Affective Disorders – A Retrospective Chart Review0
0
Correction: Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, R0
Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial0
0.040820121765137